Pictured: Vladimir Ponomarev

Vladimir Ponomarev, MD, PhD

Physician-Scientist

Clinical Expertise

Cancer Therapeutics & Drug Development; Immunology/Immunotherapy; Molecular Imaging

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Ponomarev accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me

Education

MD, State Medical University of Russia (Moscow); PhD, Institute of Pediatric Hematology of Russia (Moscow)

Residencies

Institute of Pediatric Hematology of Russia and Pediatric Hospital of Russia (Moscow)

Fellowships

Children's National Medical Center (Washington, DC); Memorial Sloan Kettering Cancer Center

I am a physician-scientist who focuses on the development of new multimodal imaging approaches for specific applications, such as sequential in vivo imaging studies in cancer biology, cancer immunotherapy, and radiation sciences.

The goal of my research is to investigate the role of dynamic gene expression imaging in tumor biology and therapy using noninvasive imaging. Specifically, my studies focus on imaging the activity of key signaling pathways involved in tumor proliferation and function influenced by tumor microenvironment. My primary aim is to develop widely applicable methods for in vivo, noninvasive monitoring of molecular-biological processes in cancer-specific cell therapies and to monitor their efficacy using multimodality molecular imaging approaches, including optical, magnetic resonance, and nuclear techniques.

My research aims to develop (a) new approaches for repetitive in vivo optical, nuclear, and magnetic resonance imaging of the fate of cancer-specific immune cells after their adoptive transfer for antitumor immunotherapy (conducted initially in animals and then in patients); (b) novel assessments of targeted drug therapies based on imaging of specific signal transduction pathways pre- and post-treatment, with the goal of rapid translation into relevant clinical studies; and (c) new multimodal genetic reporter systems for different imaging technologies to be combined during the course of the same study and in a way that harnesses the best features and utilities of each of the modalities.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

View Dr. Ponomarev's Lab

Publications on PubMed

Visit PubMed for a full listing of Dr. Ponomarev’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.